{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12971677",
  "DateCompleted": {
    "Year": "2004",
    "Month": "01",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2006",
    "Month": "06",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1027-3719",
      "JournalIssue": {
        "Volume": "7",
        "Issue": "9",
        "PubDate": {
          "Year": "2003",
          "Month": "Sep"
        }
      },
      "Title": "The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease",
      "ISOAbbreviation": "Int J Tuberc Lung Dis"
    },
    "ArticleTitle": "Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia.",
    "Pagination": {
      "StartPage": "903",
      "EndPage": "906",
      "MedlinePgn": "903-6"
    },
    "Abstract": {
      "AbstractText": [
        "Latvia, a country with levels of multidrug-resistant (MDR) TB among the highest in the world, experienced a 58-fold increase in HIV seroprevalence among all persons tested in the country from 1996 through 2001. In addition, HIV seroprevalence among TB cases increased from 0.4% to 1.4%, and among MDR-TB cases from 0% to 5.6% from 1998 through 2001, potentially compromising gains made to date in controlling the country's MDR-TB epidemic. The following will be critical to the future of MDR-TB control in Latvia: containing HIV transmission in the country, particularly among injection drug users who comprised 72% of all HIV cases reported in the country by the end of 2001, as well as 81% of all MDR-TB cases co-infected with HIV; expanding capabilities to more rapidly detect and successfully treat patients with MDR-TB; developing mutual TB control strategies between the National TB and AIDS programs; and continuing to improve institutional infection control measures, particularly in hospitals and prisons where an increasing number of persons infected with HIV come into contact with persons with active MDR-TB."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Latvian State Center for Tuberculosis and Lung Diseases, Latvian National Tuberculosis Program, Riga, Latvia."
          }
        ],
        "LastName": "Morozova",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Riekstina",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sture",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wells",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Leimane",
        "ForeName": "V",
        "Initials": "V"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Int J Tuberc Lung Dis",
    "NlmUniqueID": "9706389",
    "ISSNLinking": "1027-3719"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Communicable Disease Control"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Outbreaks"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Multiple"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Policy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infection Control"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Latvia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Policy Making"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Seroepidemiologic Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Substance-Related Disorders"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "Tuberculosis, Pulmonary"
    }
  ]
}